Search ASX code:
Generic filters

Search ASX code:
Generic filters

Search ASX code:
Generic filters

This year. We're going Beyond.

Are AMP (ASX:AMP) shares a good value play?

AMP Ltd (ASX: AMP) shares dropped to a record low in May, can new management steer it back on track?

AMP share price

Source: Rask Media AMP 5-year share price chart

New AMP Capital CEO named

AMP has announced Shawn Johnson as the new CEO of AMP Capital. He has a colourful and decorated career, previously a Boston-based investment manager and a former US Navy Lieutenant.

On top of this, Johnson was also a former managing director and chairman of the global investing and banking giant, State Street.

Johnson will take the reins on 28 June 2021.

He will replace Boe Pahari, who was demoted to head of infrastructure equity due to shareholder disapproval stemming from a sexual harassment claim that settled in 2017.

Johnson’s appointment comes at AMP Capital’s most tumultuous time in its history with the AMP share price nearing record lows.

My thoughts on AMP

Johnson faces a gargantuan task ahead of him, especially as AMP continues to face regulatory scrutiny.

In addition, AMP is experiencing record outflows of funds from its superannuation arm.

As the great Oracle of Omaha, Warren Buffet says, “Should you find yourself in a chronically leaking boat, energy devoted to changing vessels is likely to be more productive than energy devoted to patching leaks.”

In my view, there are just a lot of ways to lose and few ways to win.

I would rather focus on businesses that are experiencing structural tailwinds as per the Rask Investment Philosophy.

If you’re on the hunt for ASX small-cap shares, check out the Rask Rockets Beyond program. You might want to hurry – the first rocket is set to launch on Tuesday!

Got $1,000? Try our #1 growth stock...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or enter your email below. We'll send you the report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Got $1,000? Try this...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or the button below. We'll email you the report.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading: